Intravitreal Ziv‐Aflibercept: Clinical Effects and Economic Impact
Sign Up to like & getrecommendations! Published in 2017 at "Asia-Pacific Journal of Ophthalmology"
DOI: 10.22608/apo.2017263
Abstract: Abstract: During the past decade, drugs that inhibit the actions of vascular endothelial growth factor (VEGF) have become standard‐of‐care treatment for a variety of chorioretinal vascular conditions. The off‐label, intravitreal use of ziv‐aflibercept (Zaltrap) has… read more here.
Keywords: intravitreal ziv; ziv aflibercept; clinical effects; ziv ... See more keywords